Skip to Main Content

Author Details

Min Gew Choi
Research Institute, National Cancer Center
1998
160
39
PMIDPaper TitleJournal TitlePublished Year
36657933Trends in vitamin D level and risk of vitamin D deficiency after gastrectomy for gastric cancer: A retrospective study of a single high-volume center experience.Clin Nutr ESPEN2023
38002099The Clinical Implication of Conversion Surgery in Patients with Stage IV Gastric Cancer Who Received Systemic Chemotherapy.Biomedicines2023
37779142Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer.Exp Mol Med2023
36980541Prognostic Significance of Esophagogastric Junction Invasion in Patients with Adenocarcinoma of the Cardia or Subcardia.Cancers (Basel)2023
37163530Meso-jejunal lymph node dissection has a survival benefit in patients with remnant gastric cancer.PLoS One2023
33999252A preoperative risk prediction model for high malignancy potential gastrointestinal stromal tumors of the stomach.Surg Endosc2022
35641282Feasibility of Gastric Tumor Xenograft (GTX)-derived Cell Lines for Individualized Anti-cancer Drug Screening.Anticancer Res2022
36396994Associations of patient-generated subjective global assessment (PG-SGA) and NUTRISCORE with survival in gastric cancer patients: timing matters, a retrospective cohort study.BMC Gastroenterol2022
35884869Clinical Significance of Preoperative Hematological Parameters in Patients with D2-Resected, Node-Positive Stomach Cancer.Biomedicines2022
34433514Comparison of transabdominal and transthoracic surgical approaches in the treatment of Siewert type II esophagogastric junction cancers: A propensity score-matching analysis.Eur J Surg Oncol2022
34743207Oncogenic KRAS promotes growth of lung cancer cells expressing SLC3A2-NRG1 fusion via ADAM17-mediated shedding of NRG1.Oncogene2022
33078315Adjuvant Chemotherapy vs. Surgery Alone for pT3N0M0 Gastric Cancer.Ann Surg Oncol2021
36945668Prognostic significance of splenectomy during completion total gastrectomy in patients with remnant gastric cancer: propensity score matching analysis.Korean J Clin Oncol2021
33854817Long-Term Oncological Outcomes of Reduced Three-Port Laparoscopic Gastrectomy for Early-Stage Gastric Carcinoma: a Retrospective Large-Scale Multi-Institutional Study.J Gastric Cancer2021
33574571Compliance with D2 lymph node dissection in reduced-port totally laparoscopic distal gastrectomy in patients with gastric cancer.Sci Rep2021
33917757PGC1α Loss Promotes Lung Cancer Metastasis through Epithelial-Mesenchymal Transition.Cancers (Basel)2021
34605706Comparison of Long-Term Efficacy in S-1 and Capecitabine With Oxaliplatin as Adjuvant Chemotherapy for Patients With Gastric Cancer After Curative Surgery: A Retrospective, Single-Center Observational Study.Technol Cancer Res Treat2021
34512204Prognostic Value of Highly Expressed Type VII Collagen (COL7A1) in Patients With Gastric Cancer.Pathol Oncol Res2021
34019591Long-term effect of simplified dietary education on the nutritional status of patients after a gastrectomy.PLoS One2021
33278599A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial<sup>â¿¿</sup>.Ann Oncol2021
31309380Comparison of Postoperative Nutritional Status after Distal Gastrectomy for Gastric Cancer Using Three Reconstructive Methods: a Multicenter Study of over 1300 Patients.J Gastrointest Surg2020
32089413High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features.Pathol Res Pract2020
32070411Comprehensive pharmacogenomic characterization of gastric cancer.Genome Med2020
33379195Impact of Radiotherapy on Kidney Function among Patients Who Received Adjuvant Treatment for Gastric Cancer: Logistic and Linear Regression Analyses.Cancers (Basel)2020
33285738Long-term oncological outcomes of laparoscopic gastrectomy for grossly early gastric cancer-mimicking advanced gastric cancer: Propensity score matching analysis.Medicine (Baltimore)2020
32739319Effect of baseline sarcopenia on adjuvant treatment for D2 dissected gastric cancer: Analysis of the ARTIST phase III trial.Radiother Oncol2020
32599987A Multi-cohort Study of the Prognostic Significance of Microsatellite Instability or Mismatch Repair Status after Recurrence of Resectable Gastric Cancer.Cancer Res Treat2020
32847073Midkine Is a Potential Therapeutic Target of Tumorigenesis, Angiogenesis, and Metastasis in Non-Small Cell Lung Cancer.Cancers (Basel)2020
32788098Comparisons of remnant primary, residual, and recurrent gastric cancer and applicability of the 8th AJCC TNM classification for remnant gastric cancer staging.Eur J Surg Oncol2020
32584935Efficacy and Safety of Ursodeoxycholic Acid for the Prevention of Gallstone Formation After Gastrectomy in Patients With Gastric Cancer: The PEGASUS-D Randomized Clinical Trial.JAMA Surg2020
32234324Long term oncological outcome of patients with grossly early gastric cancer-mimicking advanced gastric cancer.Eur J Surg Oncol2020
32290335Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer.Cancers (Basel)2020
31500870Prognostic value of mismatch repair deficiency in patients with advanced gastric cancer, treated by surgery and adjuvant 5-fluorouracil and leucovorin chemoradiotherapy.Eur J Surg Oncol2020
29503057Prognostic significance of perioperative nutritional parameters in patients with gastric cancer.Clin Nutr2019
31301150A prediction model for lymph node metastasis in early-stage gastric cancer: Toward tailored lymphadenectomy.J Surg Oncol2019
31354213A comparison of short-term postoperative outcomes including nutritional status between gastrectomy with simultaneous cholecystectomy and gastrectomy only in patients with gastric cancer.Chin J Cancer Res2019
31315834Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial.Cancer Discov2019
31570486Clinical Outcomes and the Role of Adjuvant Concurrent Chemoradiation Therapy in D2-resected LN-positive Young Patients (⿤45 Years) With Gastric Cancer.Anticancer Res2019
31125843Prognostic Impact of Increased Perioperative Platelet Count in Gastric Cancer Patients.J Surg Res2019
30944764Short-Term Outcomes of Intracorporeal Delta-Shaped Gastroduodenostomy Versus Extracorporeal Gastroduodenostomy after Laparoscopic Distal Gastrectomy for Gastric Cancer.J Gastric Cancer2019
30801717Bridging genomics and phenomics of gastric carcinoma.Int J Cancer2019
31026342QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.Int J Cancer2019
31048579Prognostic Impact of Microsatellite Instability in Asian Gastric Cancer Patients Enrolled in the ARTIST Trial.Oncology2019
30539490ASO Author Reflections: Use of the Survival Recurrent Network for Prediction of Overall Survival in Patients with Gastric Cancer.Ann Surg Oncol2019
30282450Comparison of the 7th and the 8th AJCC Staging System for Non-metastatic D2-Resected Lymph Node-Positive Gastric Cancer Treated with Different Adjuvant Protocols.Cancer Res Treat2019
29214773Protective Effects of Female Reproductive Factors on Lauren Intestinal-Type Gastric Adenocarcinoma.Yonsei Med J2018
30182332Factors Associated With Host Immune Response and Number of Lymph Nodes: A Large Retrospective Cohort Study.Ann Surg Oncol2018
30097497Discovery and Validation of Salivary Extracellular RNA Biomarkers for Noninvasive Detection of Gastric Cancer.Clin Chem2018
30013197Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer.Nat Med2018
30037498Necessity of adjuvant concurrent chemo-radiotherapy in D2-resected LN-positive gastric cancer.Radiother Oncol2018
  • 1 - 50 of 160

Recommended Authors

Institute for Translational Medicine, Fujian Medical University
Career Start Year 2017
Number of shared co-authors 0
The Second Affiliated Hospital of Zhejiang University
Career Start Year 2016
Number of shared co-authors 0
Children's Hospital of Philadelphia
Career Start Year 2015
Number of shared co-authors 0
Korea University Anam Hospital, Korea University College of Medicine
Career Start Year 2012
Number of shared co-authors 7
Peter MacCallum Cancer Centre
Career Start Year 2012
Number of shared co-authors 0
National Defense Medical College
Career Start Year 2012
Number of shared co-authors 0
Singapore General Hospital
Career Start Year 2010
Number of shared co-authors 0
Centro Hospitalar Universitario do Porto (CHUP).
Career Start Year 2009
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2008
Number of shared co-authors 0
Peking University Cancer Hospital and Institute
Career Start Year 2008
Number of shared co-authors 0
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 1
Royal Melbourne Hospital, University of Melbourne
Career Start Year 2001
Number of shared co-authors 1
Goldman School of Medicine, Ben Gurion University
Career Start Year 2001
Number of shared co-authors 1
Weill Cornell University
Career Start Year 2000
Number of shared co-authors 0
General Hospital of Tibet Area Military Command
Career Start Year 1997
Number of shared co-authors 0
National Defense Medical College
Career Start Year 1997
Number of shared co-authors 0
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Career Start Year 1997
Number of shared co-authors 0
Xuzhou Central Hospital
Career Start Year 1996
Number of shared co-authors 0
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Wonju Severance Christian Hospital
Career Start Year 1993
Number of shared co-authors 3
Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine
Career Start Year 1993
Number of shared co-authors 1
National Defense Medical College
Career Start Year 1993
Number of shared co-authors 1
University of Miyazaki
Career Start Year 1988
Number of shared co-authors 0
Centro Hospitalar Universitario de Sao Joao.
Career Start Year 1986
Number of shared co-authors 0
University of California San Diego
Career Start Year 1985
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 1983
Number of shared co-authors 0
Korea Advanced Institute of Science and Technology (KAIST)
Career Start Year 1982
Number of shared co-authors 3
Leiden University Medical Center: Leids Universitair Medisch Centrum.
Career Start Year 1977
Number of shared co-authors 1

Collaborators

Seoul National University College of Medicine
Co-authored papers 58
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 42
Busan Paik Hospital, Inje University
Co-authored papers 28
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 28
Samsung Medical Center, Sungkyunkwan University
Co-authored papers 4
Co-authored papers 4
James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine
Co-authored papers 4
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers 3
Co-authored papers 3
Samsung Genome Institute, Samsung Medical Center
Co-authored papers 3
University of California San Diego Moores Cancer Center
Co-authored papers 3
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 2
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 2
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 2
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 2
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers 2
Touro College of Osteopathic Medicine
Co-authored papers 2
Korea University, College of Medicine
Co-authored papers 2
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers 2
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 2
Inha University
Co-authored papers 2
Merck & Co., Inc.
Co-authored papers 2
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers 2
University of Chinese Academy of Sciences
Co-authored papers 1
Co-authored papers 1
David Geffen School of Medicine at University of California los angeles
Co-authored papers 1
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Co-authored papers 1
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Co-authored papers 1
Genomic Medicine Institute, Medical Research Center, Seoul National University
Co-authored papers 1
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 1